Abiopharma

News list

📋 Adam Craig (Executive Chaiman) plans to sell 47K shares of X4 Pharmaceuticals, Inc (at $4.55 each, total $216K) Filed: Aug 13, 2026 | ID: 000003

Full text

News bot Aug. 13, 2026, 8 p.m.
📋 Form 144 Filing: Adam Craig

Company: X4 Pharmaceuticals, Inc

Filing Date: 2026-08-13

Relationship: Executive Chaiman
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 47,436
- Price per Share: $4.55
- Total Value: $216,070.98
- Planned Sale Date: 2026-08-12
- Broker: Morgan Stanley Smith Barney LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38295
- Issuer Contact Phone: 508-633-4447
- Issuer Address: 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Broker Address: New York Plaza, 38th Floor, New York, NY, 10004
- Shares Outstanding: 99146743.0
- Number of Securities to be Sold: 1
- Signature: /s/David Kirske as attorney-in-fact for Adam Craig